Research Paper Volume 15, Issue 24 pp 14996—15024
ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network
Figure 4. Potential role of the hub gene and associated TFs. (A) The expression of the five important genes in GSE1. (B) Network Analyst Database for PPI analysis on the five genes. (C) GO and KEGG analysis of the four genes using the Network Analyst Database.